Here the authors show that METTL3, a RNA methyltransferase that catalyzes mRNA m6 modifications, negatively regulates NASH progression via inhibiting the transcription of Cd36 and Ccl2. This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatohepatitis.